Technical Analysis for GNTA - Genenta Science S.p.A.

Grade Last Price % Change Price Change
A 5.45 6.86% 0.35
GNTA closed up 6.86 percent on Friday, November 1, 2024, on 40 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
20 DMA Resistance Bearish 6.86%
New Downtrend Bearish 6.86%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 6.86%
Wide Bands Range Expansion 6.86%
Down 3 Days in a Row Weakness 6.86%
20 DMA Resistance Bearish 2.16%
Wide Bands Range Expansion 2.16%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Genenta is a clinical-stage biotechnology company pioneering the development of a proprietary hematopoietic stem cell gene therapy for the treatment of a variety of solid tumor cancers. Temferon™ is based on ex-vivo gene transfer into autologous hematopoietic stem/progenitor cells (HSPCs) to deliver immunomodulatory molecules directly via tumor-infiltrating monocytes/macrophages (Tie2 Expressing Monocytes - TEMs). TemferonTM, which is under investigation in a Phase 1/2a clinical trial in newly diagnosed Glioblastoma Multiforme patients who have an unmethylated MGMT gene promoter (uMGMT-GBM), is based on our platform technology which is not restricted to pre-selected tumor antigens nor type and may reach solid tumors, one of the main unresolved challenges in immuno-oncology.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Biology Solid Tumors Oncology Cancer Immunotherapy Gene Therapy Cell Biology Glioblastoma Platform Technology Brain Tumor Solid Tumor Cancers Glioblastoma Multiforme

Is GNTA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.28
52 Week Low 2.2
Average Volume 15,445
200-Day Moving Average 3.95
50-Day Moving Average 4.60
20-Day Moving Average 5.48
10-Day Moving Average 5.28
Average True Range 0.53
RSI (14) 55.75
ADX 27.0
+DI 19.00
-DI 19.05
Chandelier Exit (Long, 3 ATRs) 5.68
Chandelier Exit (Short, 3 ATRs) 5.99
Upper Bollinger Bands 6.36
Lower Bollinger Band 4.60
Percent B (%b) 0.48
BandWidth 32.17
MACD Line 0.19
MACD Signal Line 0.26
MACD Histogram -0.0717
Fundamentals Value
Market Cap 99.28 Million
Num Shares 18.2 Million
EPS -0.78
Price-to-Earnings (P/E) Ratio -6.99
Price-to-Sales 0.00
Price-to-Book 2.22
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.80
Resistance 3 (R3) 5.76 5.60 5.74
Resistance 2 (R2) 5.60 5.52 5.62 5.72
Resistance 1 (R1) 5.53 5.46 5.57 5.57 5.70
Pivot Point 5.37 5.37 5.39 5.39 5.37
Support 1 (S1) 5.30 5.29 5.34 5.34 5.20
Support 2 (S2) 5.14 5.23 5.16 5.18
Support 3 (S3) 5.07 5.14 5.16
Support 4 (S4) 5.11